Bio-Techne's market cap is currently ―. The company's EPS TTM is $1.386; its P/E ratio is 50.75; and it has a dividend yield of 0.45%. Bio-Techne is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $0.45. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 272.60M	$ 276.94M	$ 301.32M	$ 294.15M	$ 271.58M
Gross Profit	$ 176.59M	$ 185.19M	$ 204.70M	$ 202.16M	$ 183.36M
EBIT	$ 37.72M	$ 54.45M	$ 96.32M	$ 78.83M	$ 67.89M
EBITDA	$ 65.52M	$ 82.99M	$ 123.25M	$ 105.80M	$ 94.59M
Net Income Common Stockholders	$ 27.46M	$ 50.99M	$ 75.37M	$ 70.22M	$ 50.01M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 135.65M	$ 148.66M	$ 204.31M	$ 157.20M	$ 196.76M
Total Assets	$ 2.73B	$ 2.76B	$ 2.64B	$ 2.60B	$ 2.36B
Total Debt	$ 555.70M	$ 549.53M	$ 454.96M	$ 473.99M	$ 289.16M
Net Debt	$ 420.05M	$ 400.87M	$ 250.66M	$ 316.79M	$ 92.40M
Total Liabilities	$ 767.19M	$ 757.61M	$ 672.18M	$ 710.01M	$ 536.29M
Stockholders Equity	$ 1.96B	$ 2.00B	$ 1.97B	$ 1.89B	$ 1.83B
Cash Flow	-
Free Cash Flow	$ 68.25M	$ 45.79M	$ 72.56M	$ 38.79M	$ 58.27M
Operating Cash Flow	$ 83.12M	$ 59.38M	$ 83.39M	$ 50.53M	$ 64.38M
Investing Cash Flow	$ -23.67M	$ -154.11M	$ -4.76M	$ -241.10M	$ -109.00K
Financing Cash Flow	$ -81.40M	$ 71.51M	$ -24.23M	$ 150.84M	$ -72.19M

Currency in USD

Bio-Techne Earnings and Revenue History

Income Statement >

Bio-Techne Debt to Assets

Balance Sheet >

Bio-Techne Cash Flow

Cash Flow >

Bio-Techne Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing